Michelle McGuinness
Corporate Officer/Principal bei Huntington's Disease Society of America
Profil
Ms. Michelle McGuinness is VP-Regulatory Affairs & Quality Assurance at Veloxis Pharmaceuticals A/S and a Director-Southeastern Pennsylvania Chapter at Huntington's Disease Society of America.
She received her undergraduate degree from Kean University and a graduate degree from the Temple University School of Pharmacy.
Aktive Positionen von Michelle McGuinness
| Unternehmen | Position | Beginn |
|---|---|---|
| Huntington's Disease Society of America | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michelle McGuinness
| Unternehmen | Position | Ende |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | General Counsel | - |
Ausbildung von Michelle McGuinness
| Temple University School of Pharmacy | Graduate Degree |
| Kean University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Huntington's Disease Society of America |
